[Botulinum Toxin in Functional Hypersalivation--All about Dosage?]

Area of Science:

• Otolaryngology
• Neurology
• Pharmacology

Background:

• Salivary gland botulinum toxin injections are increasingly used for functional hypersalivation.
• Current dosage guidelines are not standardized due to off-label use and variable success rates.

Purpose of the Study:

• To analyze the efficacy and safety of botulinum toxin dosage levels in treating hypersalivation.
• To determine optimal dosing strategies for improved clinical outcomes.

Main Methods:

• Retrospective analysis of 54 patients and 117 treatments over 5 years.
• Evaluation of botulinum toxin dosage, treatment outcomes, and adverse events.

Main Results:

• 90% of patients experienced reduced saliva production.
• Increased dosages were used in subsequent treatments to enhance efficacy.
• Common side effects included swallowing difficulties and viscous saliva, particularly in patients with tracheostomies, and were largely dose-independent.

Conclusions:

• Botulinum toxin injections are an effective treatment for hypersalivation with generally minor side effects, even at higher doses.
• Individualized treatment modifications are necessary for optimal results.
• Informed consent should address potential side effects like swallowing problems and treatment non-response, which can occur even with higher dosages.